Login
Companies $OPRX
$6.76 +$0.12 (1.81%) After hours
OptimizeRx Corp logo

OptimizeRx Corp

optimizerx.com

What Do They Do?

Runs digital audience-targeting and marketing campaigns for pharmaceutical and life sciences brands, reaching healthcare professionals and patients.

How Do They Make Money?

Life sciences customers pay for delivered messages and campaign services, with fees per message or redemption, flat fees over time, or a fee when a program is completed; some also buy data subscriptions.

revenue
SegmentShareRevenue
Revenue recognized over time
100%
Revenue recognized at a point in time
Sold outright
0.2%

Who Are Their Customers?

Pharmaceutical manufacturers and life sciences brands, plus their agency partners, are the advertiser clients; campaigns reach audiences through publisher partners and EHR and e-prescribing platforms.

Do Revenues Turn Into Profits?

Yes. It kept 5 cents of every revenue dollar as net income in FY2025 and turned 17 cents into free cash flow.

Operating income, FY2025
11% of revenue
▲ Turned profitable vs FY2024 (−$13.7M, −15%)
Net income, FY2025
5% of revenue
▲ Turned profitable vs FY2024 (−$20.1M, −22%)
Free cash flow, FY2025
17% of revenue
▲ +291% vs FY2024 ($4.8M, 5%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −17%
vs $26.1M in Q3 FY2025
Net income
▲ +53%
vs $779K in Q3 FY2025
  • Aug 7, 2026 Plans finance chief succession and reaffirms full-year guidance Edward Stelmakh will step down as chief financial and strategy officer; Andrew D’Silva is slated to become chief financial officer, and the company reaffirmed its outlook.
  • May 12, 2026 Updates fiscal-year revenue guidance The company set revenue guidance at $95 million to $100 million, with adjusted EBITDA guidance unchanged.
  • Mar 24, 2026 Replaces its independent auditor The audit committee dismissed UHY and engaged Grant Thornton for the 2026 fiscal year.

Growing. Revenue grew 79% in 4 years, from $61.3M in FY2021 to $109.4M in FY2025, about 16% a year.

Broader consumer marketing The older report describes point-of-care and healthcare-provider engagement solutions; the latest report adds direct-to-consumer marketing and audience targeting by geography through MNT.

Revenue over time
Revenue recognized over time Revenue recognized at a point in time
$200M$100M$0

Who Do They Compete With?

Competes with ConnectiveRx

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support